Biologic Complexity in Sickle Cell Disease: Implications for Developing Targeted Therapeutics
Current therapy for sickle cell disease (SCD) is limited to supportive treatment of complications, red blood cell transfusions, hydroxyurea, and stem cell transplantation. Difficulty in the translation of mechanistically based therapies may be the result of a reductionist approach focused on individ...
Saved in:
| Main Author: | Beatrice E. Gee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/694146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications
by: Tarimoboere Agbalalah, et al.
Published: (2024-01-01) -
Ferroptosis as an emerging target in sickle cell disease
by: Vitor Fortuna, et al.
Published: (2024-01-01) -
The Heat Is On: Climate Change Implications for Pregnant Women with Sickle Cell Disease
by: Rachelle Chanmany Pastor, et al.
Published: (2025-01-01) -
Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia
by: Ngozi Awa Imaga
Published: (2013-01-01) -
Immune cell senescence in autoimmunity: implications for disease pathogenesis and therapeutic targeting
by: Fei Yin, et al.
Published: (2025-08-01)